Tekla Life Sciences Investors (HQL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.22M | -1.28M | -1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating CF Margin % | -2.54% | -10.96% | -5.74% | - | - | - | - | 0% | 0% | - | - | 0% |
| Operating CF Growth % | -16.71% | - | - | - | - | 100% | 100% | - | - | 100% | 100% | - |
| Net Income | 65.34M | 132.83M | -47.23M | 11.18M | 33.8M | -52.3K | -52.3K | 32.27K | 32.27K | 61.53K | 61.53K | -35.24K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -66.7M | -133.97M | 46.26M | -11.18M | -33.8M | 52.3K | 52.3K | -32.27K | -32.27K | -61.53K | -61.53K | 35.24K |
| Working Capital Changes | 139.03K | -129.61K | -73.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Receivables | -15.68K | 182.5K | -123.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 15.28K | -15.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 10.17M | 20.83M | 4.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 0% | - | - | - | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - |
| Investments | 561.89M | 514.12M | 12.16M | 412.77M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M | 483.97M | 397.21M | 381.47M |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -16.6M | -23.22M | -8.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -18.17M | -31.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.57M | 8.41M | -8.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -75.54K | 75.54K | 0 | 32 | 377 | -545 | -545 | -1 | -1 | 0 | 0 | 1.12M |
| Free Cash Flow | -1.22M | -1.28M | -1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FCF Margin % | -2.54% | -10.96% | -5.74% | - | - | - | - | 0% | 0% | - | - | 0% |
| FCF Growth % | -16.71% | - | - | - | - | 100% | 100% | - | - | 100% | 100% | - |
| FCF per Share | -0.04 | -0.04 | -0.04 | - | - | - | - | 0.00 | 0.00 | - | - | 0.00 |
| FCF Conversion (FCF/Net Income) | -0.02x | -0.01x | 0.02x | - | - | - | - | 0.00x | 0.00x | - | - | 0.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |